A 23-year-old man was initiated on acamprosate 666mg in the morning. He developed sedation and emesis [ time to reaction onset not stated ] and his dosage was reduced to 333 mg/day. His symptoms improved and he continued acamprosate for 16 weeks. COMMENT Editorial Comment : A search of ...
All participants in the study were initially given acamprosate (one 333 mg tablet three times a day for the first week) to determine their tolerance to the treatment. A standard dose of acamprosate was then prescribed (two 333 mg tablets three times a day). It is essential to highlight ...
Then, a standard dose of two 333-mg tablets three times a day was prescribed. However, the research physician prescribing acamprosate to the study participants could also choose to allow participants to remain on one 333-mg tablet three times a day in order to reduce side effects and increase...